Bahl & Gaynor’s Meredith Corporation MDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-54,598
Closed -$1.77M 370
2019
Q4
$1.77M Buy
54,598
+134
+0.2% +$4.77K 0.01% 241
2019
Q3
$2M Sell
54,464
-32,040
-37% -$1.49M 0.01% 232
2019
Q2
$4.76M Buy
86,504
+53,090
+159% +$2.97M 0.04% 145
2019
Q1
$1.85M Buy
+33,414
New +$1.86M 0.02% 223
2015
Q3
Sell
-14,510
Closed -$757K 444
2015
Q2
$757K Buy
14,510
+4,795
+49% +$254K 0.01% 264
2015
Q1
$542K Buy
9,715
+265
+3% +$14.2K 0.01% 297
2014
Q4
$513K Buy
9,450
+800
+9% +$40.1K 0.01% 292
2014
Q3
$370K Buy
+8,650
New +$403K 0.01% 327

Other funds holding MDP

Bahl & Gaynor's MDP Position: Q1 2020 in Review

Bahl & Gaynor sold out of Meredith Corporation (MDP) in Q1 2020, closing a stake of 54,598 shares — an estimated $1.77M sold.

Bahl & Gaynor first reported a position in MDP in Q3 2014 and held it in 8 quarters. The position peaked at $4.76M in Q2 2019. 216 funds tracked by Wall St. Rank hold MDP as of Q1 2020.

  • Bahl & Gaynor reported no remaining Meredith Corporation position as of Q1 2020 after selling out during the quarter.
  • Bahl & Gaynor sold 54,598 Meredith Corporation shares in Q1 2020, an estimated $1.77M.
  • Bahl & Gaynor first reported a position in Meredith Corporation in Q3 2014 and held it in 8 quarters.
  • Bahl & Gaynor's Meredith Corporation position peaked at $4.76M in Q2 2019.
  • 216 funds tracked by Wall St. Rank held Meredith Corporation as of Q1 2020.

Based on Bahl & Gaynor's 13F filing for Q1 2020, filed 15 May 2020.